Sorted By Test Name - Mayo Medical Laboratories

FADA
91554
81444
(50-70 x normal) ADA activity are associated with reduced concentrations of ATP. This hemolytic
disorder is inherited in an autosomal dominant pattern, in contrast to most erythrocyte enzymopathies.
Elevated ADA is also seen in Diamond Blackfan anemia (DBA) and may be used as supportive evidence
in the differential diagnosis of transient erythroblastopenia of childhood. Approximately 20% of severe
combined immunodeficiency disease (SCID) patients are associated with ADA deficiency. This test can
be used in combination with clinical features and corroborative laboratory testing to support a diagnosis
subtype for suspected SCID patients.
Useful For: Evaluation of hemolytic anemia of obscure cause Evaluation of severe combined
immunodeficiency syndrome
Interpretation: In hemolytic anemia due to adenosine deaminase (ADA) excess, ADA concentrations
are 48 U/g hemoglobin to 100 U/g hemoglobin. In severe combined immunodeficiency syndrome, ADA
concentrations are 3.0 g/dL: 1.6-9.2 U/L
Pleural Transudate:
Total protein 2.0 g/dL: 0-7.6 U/L
Peritoneal Transudate:
Total protein